SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The sharp rally has no confirmed company-news catalyst; traders are focused on anticipation of the REGAL Phase 3 final analysis, which is triggered at 80 survival events after the last disclosed count of 78. Some interpret the CEOs anniversary message and SELLASs planned ASH presence as signs of a potential buyout, while others call that speculation and see the move as a rebound or possible short covering.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the dominant focus, with traders watching guidance, subscriber engagement and advertising growth amid concerns about competition and a prolonged share-price decline. Many expect further weakness, while bulls argue pessimism is already priced in and see room for a rebound if results or the outlook are stronger than feared.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is drawing attention as traders position around the full Phase 3 melanoma results for its personalized cancer vaccine, intismeran, with Merck; the prior positive topline result has fueled a sharp rally. Bulls see validation of a broader oncology platform, while skeptics warn that expectations and valuation are stretched and debate a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is being attributed by traders to possible short covering and anticipation of upcoming DM1 and FSHD siRNA data, with Arrowheads RNAi results cited as supportive context. No new Sarepta catalyst is confirmed in the discussion, and some traders view the move as technical or part of broader biotech strength.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs steep selloff is being discussed amid broader neocloud concerns about financing, AI infrastructure spending returns, and whether providers can remain independent; traders also point to dilution and possible project delays. The community is split between bearish views that the weakness may persist and bullish arguments that IRENs cash-funded data centers and customer prepayments distinguish it from more debt-heavy peers.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings beat and new share-repurchase authorization are being overshadowed by a narrowed full-year profit outlook whose midpoint was unchanged, prompting a sharp selloff. Traders are split between viewing the buyback and stronger cash-flow outlook as support and seeing cautious guidance, lower U.S. sales, and cost pressures as reasons for the decline.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solanas volatile pullback and bounce amid broader crypto weakness are driving discussion, with traders watching support and Bitcoins direction. Dip-buyers are accumulating and staking, while bearish traders warn the recovery may fail and expect further downside.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA is drawing attention as it approaches and tests its 200-day moving average ahead of earnings, with traders watching for stronger volume and sustained momentum. Optimism about ASCENIV growth and share repurchases is tempered by calls for earnings to validate the outlook and lingering concerns over BIVIGAM weakness and management credibility.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash transaction as a potential balance-sheet and strategic reset. Bulls welcome the deal and momentum, while skeptics argue the sale removes a revenue-generating business and leaves concerns about declining operations and debt; the transaction remains subject to approval.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is drawing attention after a sharp post-earnings selloff despite beating expectations, as investors focused on slower U.S. da Vinci procedure growth and a cautious outlook. Traders are split between viewing the decline as an overreaction given the companys robotic-surgery position and recurring revenue, and seeing valuation, competition, and growth uncertainty as reasons for a reset.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

nCino Partners with Parlay to Power AI-Native SBA Lending Nationwide

Parlay, the AI-native Loan Intelligence System (LIS) and nCino (NASDAQ: NCNO), the platform for agentic AI banking, today announced a partnership to streamline intake for America's 1,400 Small Business Administration (SBA) lenders. Parlay now connects directly into nCino's Commercial and Small...

nCino's 2026 Outlook: AI-Driven Agentic Workflows Drive Sustainable Profitability

Key PointsThe company achieved its first year of GAAP profitability in 2026...

nCino (NCNO)'s Technical Outlook is Bright After Key Golden Cross

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

nCino (NCNO) Q2 2027 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Why nCino Stock Is Rising Today

Key PointsnCino reported Q2 2027 financial results yesterday...

Futures Flat Ahead Of Key PCE Report, Nvidia Earnings

Futures Flat Ahead Of Key PCE Report, Nvidia Earnings

 Stock futures are are flat and Treasuries slipped while oil stumbled heading into today's PCE report and NVDA earnings. As of 8:00am ET, S&P Futures are unchanged and Nasdaq futures drop 0.2% as?NVDA and MRVL both rise 0.2% with...

Full Transcript: Ncino Q2 2027 Earnings Call

On Tuesday, Ncino (NASDAQ:NCNO) discussed second-quarter financial results during its earnings call. The full transcript is provided below.
This content is powered by Benzinga APIs. For comprehensive financial data andread more...

nCino (NCNO) Tops Q2 Earnings and Revenue Estimates

nCino (NCNO) delivered earnings and revenue surprises of +7.14% and +1.27%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

nCino and Dun & Bradstreet Collaborate to Speed Client Onboarding and Enhance Lifecycle Management for Financial Institutions

nCino and Dun & Bradstreet Collaborate to Speed Client Onboarding and Enhance Lifecycle Management for Financial Institutions nCino and Dun & Bradstreet Collaborate to Speed Client Onboarding and Enhance Lifecycle Management for Financial Institutions PR Newswire JACKSONVILLE, Fla. and WILMINGTON...

Cisco Systems (CSCO) Beats Q4 Earnings and Revenue Estimates

Cisco (CSCO) delivered earnings and revenue surprises of +4.27% and +2.36%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

nCino, Inc. engages in the provision of cloud-based software applications for financial institutions in the United States and internationally. Its nCino Bank Operating System, a tenant cloud platform, digitizes, automates, and streamlines complex processes and workflow, and utilizes data analytics and artificial intelligence and machine learning (AI/ML) to enable financial institutions to onboard new clients, make loans, and manage the entire loan life cycle, open deposit and other accounts, and manage regulatory compliance. The firm's nCino IQ is an application suite that utilizes data analytics and AI/ML to provide its customers with automation and insights into their operations, such as tools for analyzing, measuring, and managing credit risk, as well as to enhance their ability to comply with regulatory requirements. The company was founded by Pierre Naudé in 2011 and is headquartered in Wilmington, NC.

Ncino Inc.

NCNO Stock Posts Best Day In 7 Months After Strong Q4: Analysts Still See Over 50% Upside

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>NCNO shares jumped over 10% on Wednesday, after fourth-quarter results came in higher than expectations.</li><li>The financial software firm announced new contracts with a global financial institution in Japan and a top-three Austrian bank.</li><li>Stocktwits sentiment for NCNO is ‘extremely bullish.’</li></ul>NCino Inc. shares surged 10.6% on Wednesday, marking their strongest single-day gain in over seven months, after the financial software firm delivered better-than-expected quarterly results and issued an upbeat annual outlook.The NCNO ticker also lit up on Stocktwits, drawing heavy late-day buzz as retail sentiment flipped from ‘neutral’ to ‘extremely bullish,’ supported by a wave of positive analyst calls.“$NCNO loading zone,”&nbsp;<a href="https://stocktwits.com/cntrade1/message/649213632">said</a> a user, while another&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.stocktwits.com/topstockalerts/message/649155563">said</a>, “$20’s ahead,” referring to their price target. Many also welcomed the rally, noting that it comes at a time when software stocks are under broad pressure.NCino is a cloud-based banking software platform that helps financial institutions digitize operations like loans, account opening, onboarding, compliance, and portfolio management, with AI improving decision-making and efficiency. It serves over 2,700 customers, including banks and credit unions.<h2 class="st-heading-2">Analyst’s View On NCNO</h2>Following the earnings report&nbsp;late Tuesday,&nbsp;Wall Street remained broadly constructive, although several price target cuts reflected a more cautious valuation backdrop for software stocks.Piper Sandler upgraded nCino to ‘Overweight’ from ‘Neutral’ with a price target of $22, down from $30. The research firm called the report "healthy" and the outlook "prudent," highlighting "strong" early renewal activity and&nbsp;landing marquee international customers.Morgan Stanley kept its 'Overweight' rating and raised its price target to $23 from $21, telling investors that nCino's Pricing and Banking Advisor products are scaling faster than expected, reinforcing the firm's conviction that growth should accelerate in fiscal 2027 and beyond.Goldman Sachs maintained its 'Neutral' rating while trimming its target to $24 from $28. The firm noted that nCino reported fourth-quarter revenue and adjusted operating profit roughly 1% and 5% above consensus, respectively, driven by 17% annual contract value growth. Goldman flagged a modest deceleration in organic subscription growth to 7% but added that the setup points to accelerating subscription revenue growth ahead.Truist remained a bit more cautious. Analyst Terry Tillman cut his price target to $19 from $27 while keeping a 'Hold' rating, acknowledging that AI-led expansion and improved pipeline conversion drove strength in the quarter and management appears to be executing against its stated priorities. However, Tillman noted that growth remains modest relative to peers and that the firm's valuation reset reflects broader software-sector pressure driven by AI-related fears.Overall, 11 of 17 analysts covering nCino rate it 'Buy' or higher, with six at 'Hold,' per Koyfin. The average price target of $26.07 implies roughly 57% upside from the stock's last close.<h2 class="st-heading-2">Q4 Results Recap</h2>Revenue in the fiscal fourth quarter rose 6% to $149.7 million, and adjusted income doubled to $0.37 per share from $0.19. Both came in higher than analysts’ expectations of $147.9 million revenue and $0.21 per share earnings.The company announced new contracts with a global financial institution in Japan and a top-three Austrian bank, as well as expanded work with two large existing customers.It also authorized an additional $100 million share repurchase to be completed under an accelerated share repurchase.For its fiscal 2027, NCino&nbsp;forecasts revenue of $639 million to $643 million, representing 7.8% annual growth. It expects adjusted operating income of $165 million to $170 million, which is higher than analysts’ forecast of $154.3 million.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the nCino company logo is seen displayed on a smartphone screen.

Following the Q4 earnings report, Wall Street remained broadly constructive on NCNO, although several price target cuts reflected a more cautious valuation backdrop for software stocks.

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$21.56
Prev Close	$20.35
Open	$20.22
Dividend Yield	0.00%
50-Day Moving Average	$20.58
Beta	0.98
Avg. Volume	2.36M
PE Ratio	67.45

52-Week High	$27.50
52-Week Low	$13.80
Market Capitalization	$2.15B
EPS (Annual)	$0.0453
Price to Book	2.30
Revenue Per Employee	$353,195.37

Feed

News

Sentiment

Earnings

Fundamentals

Info

NCNO Fundamentals